Stryker Q3 organic sales +9.9% to $4.5B; adj EPS $2.12 -3.6%; guides FY adj EPS $9.15-$9.25

STRYKER CORP

2022-Q3 EPS reported $4.70 revenue$13,247,000,000

Net sales $4.5B (+7.7% reported, +9.9% organic); MedSurg & Neuro +10.8% organic, Ortho & Spine +8.7%.
Reported EPS $2.14 (+87.7%); adjusted EPS $2.12 (-3.6%); adjusted operating margin 22.3% (-310 bps).
FY 2022 organic net sales growth guidance raised to 8.5%-9.0%; currency to hit sales ~4% and adj EPS $0.35-$0.40.
Adjusted EPS guidance narrowed to $9.15-$9.25 from prior view, citing inflation and FX headwinds.
CEO cites strong capital equipment order book and sales momentum despite product shortages.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

STRYKER CORP reported third quarter of 2022 results: revenue $4.5 billion, net income $816 million, EPS $2.14. Guidance lowered.

Period: third quarter of 2022
Revenue: $4.5 billion
Net income: $816 million
EPS: $2.14
Guidance: lowered
Result: reported results

Exact text from the filing

Stryker (NYSE:SYK) reported operating results for the third quarter of 2022: Third Quarter Results • Reported net sales increased 7.7% to $4.5 billion • Organic net sales increased 9.9% • Reported operating income margin of 18.0% • Adjusted operating income margin (1) contracted 310 bps to 22.3% • Reported EPS increased 87.7% to $2.14 • Adjusted EPS (1) decreased 3.6% to $2.12

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

STRYKER CORP filing history →

Source: SEC EDGAR

accession 0000310764-22-000103

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.